West Virginia Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 18 (64% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 9,762
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 6.08%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 1,411
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 8.71%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 86.95% 87.60%
White, Hispanic/Latino Patients 1.09% 1.98%
Black/African American, Non-Hispanic/Latino Patients 3.01% 3.12%
Black/African American, Hispanic/Latino Patients 0.14% 1.49%
Asian Patients3 0.12% 0.14%
American Indian/Alaska Native Patients3 0.10% 0.21%
Native Hawaiian/Other Pacific Islander Patients3 0.07% 0.00%
Patients with More than one race3 0.83% 0.57%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.26% 0.85%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.02% 1.49%
Unreported/Refused to Report Race and Ethnicity 4.40% 2.55%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 828
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 14.69%
COVID-19 Immunization Series Completed 687
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 8.96%
COVID-19 Immunization Series Additional 1,753
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 5.51%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 79.23% 84.28% 89.96%
White, Hispanic/Latino Patients 0.36% 1.31% 0.00%
Black/African American, Non-Hispanic/Latino Patients 12.56% 4.95% 4.68%
Black/African American, Hispanic/Latino Patients 0.00% 0.15% 0.00%
Asian Patients3 0.12% 0.00% 0.00%
American Indian/Alaska Native Patients3 0.00% 0.15% 0.34%
Native Hawaiian/Other Pacific Islander Patients3 0.00% 0.00% 0.00%
Patients with More than one race3 0.48% 1.16% 0.23%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.12% 0.58% 0.00%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 0.24% 1.02% 4.11%
Unreported/Refused to Report Race and Ethnicity 6.88% 6.40% 0.68%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 16.67%
1 to 24 Hours 22.22%
More Than 24 Hours 55.56%
N/A 5.56%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 5.56%
Staffing to administer the vaccine 44.44%
Vaccine confidence 27.78%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 5.56%
None 22.22%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 33.33%
Average Percent of Health Center Visits Conducted Virtually 18.33%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 33.33%
Number of Mobile Van Sites 3
Number of Pop-up Clinics 3
Number of School-Based Vaccination Sites 13

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 11.11%
Refer patients to another organization that provides monoclonal antibody therapies 44.44%
None 44.44%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 5.56%
Patient awareness/education 0.00%
Staffing capacity 16.67%
Therapy administration/onsite logistics 16.67%
Other 5.56%
None 55.56%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021